PEOPLE - Neoprobe Corporation (US) elects board member:
This article was originally published in Clinica
Executive Summary
Dublin, Ohio-based Neoprobe Corporation, an oncology and cardiovascular surgical and diagnostic product developer, has announced that Kirby Bland has been elected to the company's board of directors. Dr Bland is chairman of the department of surgery at University Hospital and surgeon-in-chief at the Kirklin Clinica in Birmingham, Alabama.
You may also be interested in...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.